TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Nanosonics Limited ( (AU:NAN) ).
Nanosonics Limited has announced the application for quotation of 189,870 ordinary fully paid securities on the Australian Securities Exchange (ASX). This move, involving securities issued under an employee incentive scheme, is part of the company’s strategic efforts to enhance its market presence and operational capabilities.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.00 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the healthcare industry, focusing on infection prevention solutions. The company is known for its innovative products designed to improve patient safety and reduce the risk of infection transmission.
Average Trading Volume: 767,482
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.39B
For a thorough assessment of NAN stock, go to TipRanks’ Stock Analysis page.